TLSI(TLSI)
TLSI
ANALYST COVERAGE3 analysts
BUY
▲ +177.8%upside to target
PRICE
Prev Close
2.68
Open
2.48
Day Range2.48 – 2.88
2.48
2.88
52W Range2.20 – 7.95
2.20
7.95
12% of range
VOLUME & SIZE
Avg Volume
348.7K
FUNDAMENTALS
P/E Ratio
-2.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
27
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 94 days
Aug 20
Key MetricsTTM
Market Cap$108.04M
Revenue TTM$44.88M
Net Income TTM-$27.31M
Free Cash Flow-$20.30M
Gross Margin85.1%
Operating Margin-62.4%
Net Margin-60.9%
Return on Equity162.6%
Return on Assets-38.5%
Debt / Equity2.69
Current Ratio5.78
EPS TTM$-0.53
TLSI News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Jodi DevlinChief of Clinical Strategy & Operations
Mary T. SzelaChief Executive Officer, President & Director
Andrea MarassoVice President of Marketing
Bryan F. CoxChief of Research
Richard MarshakChief Commercial Officer
Richard MarshallMedical Director
David PatienceChief Financial Officer
Jennifer L. StevensChief Regulatory Officer